NO20021035L - Fremgangsmåter for anvendelse av rasktvirkende selective serotonin gjenopptakningsinhibitorer for behandling av seksuelldysfunksjon - Google Patents
Fremgangsmåter for anvendelse av rasktvirkende selective serotonin gjenopptakningsinhibitorer for behandling av seksuelldysfunksjonInfo
- Publication number
- NO20021035L NO20021035L NO20021035A NO20021035A NO20021035L NO 20021035 L NO20021035 L NO 20021035L NO 20021035 A NO20021035 A NO 20021035A NO 20021035 A NO20021035 A NO 20021035A NO 20021035 L NO20021035 L NO 20021035L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- serotonin reuptake
- selective serotonin
- sexual dysfunction
- rapidly
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15243599P | 1999-09-03 | 1999-09-03 | |
PCT/US2000/020788 WO2001017521A1 (en) | 1999-09-03 | 2000-08-22 | Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20021035D0 NO20021035D0 (no) | 2002-03-01 |
NO20021035L true NO20021035L (no) | 2002-05-02 |
NO330562B1 NO330562B1 (no) | 2011-05-16 |
Family
ID=22542905
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20021035A NO330562B1 (no) | 1999-09-03 | 2002-03-01 | Anvendelse av dapoksetin for fremstilling av et medikament for behandling eller handtering av seksuell dysfunksjon |
NO2012015C NO2012015I2 (no) | 1999-09-03 | 2012-09-11 | Dapoxetine |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO2012015C NO2012015I2 (no) | 1999-09-03 | 2012-09-11 | Dapoxetine |
Country Status (34)
Country | Link |
---|---|
US (4) | US7718705B1 (no) |
EP (3) | EP1889614A3 (no) |
JP (1) | JP3194734B2 (no) |
KR (1) | KR100719977B1 (no) |
CN (1) | CN1222283C (no) |
AT (1) | ATE318135T1 (no) |
AU (1) | AU762934B2 (no) |
BE (1) | BE2012C040I2 (no) |
BG (1) | BG65677B1 (no) |
BR (1) | BR0014166A (no) |
CA (1) | CA2383785C (no) |
CY (1) | CY2012028I2 (no) |
CZ (1) | CZ299712B6 (no) |
DE (2) | DE122009000036I2 (no) |
DK (1) | DK1225881T3 (no) |
EA (1) | EA004101B1 (no) |
EE (1) | EE05315B1 (no) |
ES (2) | ES2256032T3 (no) |
FR (1) | FR12C0052I2 (no) |
HK (2) | HK1047545B (no) |
HR (1) | HRP20020189A2 (no) |
HU (1) | HU229150B1 (no) |
IL (2) | IL148159A0 (no) |
LU (1) | LU92204I2 (no) |
MX (1) | MXPA02001811A (no) |
MY (1) | MY125490A (no) |
NO (2) | NO330562B1 (no) |
NZ (1) | NZ517038A (no) |
PL (1) | PL211402B1 (no) |
SI (1) | SI1225881T1 (no) |
TW (3) | TWI312678B (no) |
UA (1) | UA75580C2 (no) |
WO (1) | WO2001017521A1 (no) |
ZA (1) | ZA200201407B (no) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6403597B1 (en) | 1997-10-28 | 2002-06-11 | Vivus, Inc. | Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
WO2001017521A1 (en) * | 1999-09-03 | 2001-03-15 | Eli Lilly And Company | Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction |
DE60211689T2 (de) | 2001-03-16 | 2007-01-11 | DMI Biosciences, Inc., Englewood | Verwendung von Tramadol zur Verzögerung der Ejakulation |
EE200300478A (et) | 2001-03-29 | 2003-12-15 | Bristol-Myers Squibb Company | Tsüklopropüülindooli derivaadid kui selektiivsed serotoniini tagasihaarde inhibiitorid |
CA2410966C (en) * | 2002-11-01 | 2005-11-22 | Craig J. Hudson | Sexual desire and performance enhancement with protein-bound tryptophan |
AU2003903597A0 (en) * | 2003-07-11 | 2003-07-24 | Jakov Vaisman | Treatment of premature ejaculation |
GB0318706D0 (en) * | 2003-08-08 | 2003-09-10 | Pfizer Ltd | Selective serotonin reuptake inhibitors in the treatment of disease |
DE102009015702A1 (de) | 2009-03-31 | 2010-10-07 | Ratiopharm Gmbh | Tabletten enthaltend Dapoxetin und Trockenverarbeitungsverfahren zu deren Herstellung |
DE102009058321A1 (de) * | 2009-12-15 | 2011-06-16 | Ratiopharm Gmbh | Schmelztablette, enthaltend Dapoxetin |
MX2013000001A (es) | 2010-07-06 | 2013-05-01 | Navipharm Co Ltd | Composición farmaceutica de liberacion prolongada y acción retardada que comprende dapoxetina para administaracion oral. |
RU2463033C2 (ru) * | 2010-08-06 | 2012-10-10 | Василий Федорович Пятин | Способ лечения преждевременной эякуляции |
CN103100085A (zh) * | 2011-11-09 | 2013-05-15 | 上海兰蒂斯生物医药科技有限公司 | 一种药物组合物 |
CN103130660B (zh) * | 2011-11-25 | 2014-09-17 | 厦门福满药业有限公司 | 一类达泊西汀的酸式盐及其晶体,以及晶体的制备方法 |
WO2014042416A1 (ko) * | 2012-09-13 | 2014-03-20 | 주식회사 씨티씨바이오 | 다폭세틴 유리염기를 함유하는 경구용 조성물 |
KR101432905B1 (ko) | 2012-12-11 | 2014-08-21 | 가톨릭대학교 산학협력단 | 다폭세틴을 유효성분으로 포함하는 유전적 통증 치료용 약학 조성물 |
WO2014190063A1 (en) * | 2013-05-21 | 2014-11-27 | Wynberg Jason B | Methods for the treatment of premature ejaculation |
CN103735525B (zh) * | 2014-02-12 | 2015-05-06 | 江苏仁寿药业有限公司 | 一种达泊西汀片剂及制备方法 |
CN106659755A (zh) * | 2014-08-12 | 2017-05-10 | 王天欣 | 一种处理哺乳动物性功能障碍的方法、药品及药品配方 |
US20180071269A1 (en) | 2015-08-12 | 2018-03-15 | Tianxin Wang | Therapeutical methods, formulations and nutraceutical formulations |
WO2018102233A1 (en) * | 2016-11-30 | 2018-06-07 | Wang tian xin | Therapeutical methods, formulations and nutraceutical formulations |
TR201620151A2 (en) | 2016-12-30 | 2018-07-23 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | ORAL PHARMACEUTICAL COMPOSITIONS CONTAINING TADALAFIL AND DAPOXETIN |
CN113181127A (zh) * | 2021-05-07 | 2021-07-30 | 苏州康恒研新药物技术有限公司 | 一种盐酸达泊西汀微丸片的制备方法 |
CN113143879A (zh) * | 2021-05-07 | 2021-07-23 | 苏州康恒研新药物技术有限公司 | 一种盐酸达泊西汀缓释片的制备方法 |
US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4314081A (en) * | 1974-01-10 | 1982-02-02 | Eli Lilly And Company | Arloxyphenylpropylamines |
US4018895A (en) * | 1974-01-10 | 1977-04-19 | Eli Lilly And Company | Aryloxyphenylpropylamines in treating depression |
US4194009A (en) * | 1974-01-10 | 1980-03-18 | Eli Lilly And Company | Aryloxyphenylpropylamines for obtaining a psychotropic effect |
US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
US4207343A (en) * | 1978-06-22 | 1980-06-10 | Eli Lilly And Company | 1-Phenyl-3-(substituted phenoxy)propylamines |
US4329356A (en) * | 1980-10-31 | 1982-05-11 | Eli Lilly And Company | Treatment of hypertension with fluoxetine and l-5-hydroxytryptophane |
IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
US5135947A (en) * | 1987-04-09 | 1992-08-04 | Eli Lilly And Company | 1-phenyl-3-naphthalenyloxypropanamines and their use as selective serotonin reuptake inhibitors |
US4866046A (en) | 1988-05-31 | 1989-09-12 | Top Laboratories, Inc. | Low-dosage sublingual aspirin |
US5082667A (en) | 1988-06-07 | 1992-01-21 | Abbott Laboratories | Solid pharmaceutical dosage in tablet triturate form and method of producing same |
US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
US5114976A (en) | 1989-01-06 | 1992-05-19 | Norden Michael J | Method for treating certain psychiatric disorders and certain psychiatric symptoms |
IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
US4940731A (en) | 1989-08-30 | 1990-07-10 | Pfizer Inc. | Method of treating premature ejaculation using sertraline |
US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
US5589511A (en) | 1990-08-13 | 1996-12-31 | Sepracor Inc. | Method for treating migraine headaches using optically pure S(+) fluoxetine |
US5151448A (en) | 1991-07-12 | 1992-09-29 | Crenshaw Roger T | Method for treating premature ejaculation |
US5151488A (en) * | 1991-11-12 | 1992-09-29 | The Mead Corporation | Liquid crystal polymers containing a repeating bisoxazole structure |
US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
US5248699A (en) | 1992-08-13 | 1993-09-28 | Pfizer Inc. | Sertraline polymorph |
US5292962A (en) | 1992-12-11 | 1994-03-08 | Eli Lilly And Company | Intermediates to 1-phenyl-3-naphthalenyloxy-propanamines |
US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
ZA93694B (en) | 1993-02-01 | 1993-06-03 | Lilly Co Eli | Pharmaceutical treatments. |
US5276042A (en) | 1993-04-16 | 1994-01-04 | Crenshaw Roger T | Treatment of premature ejaculation |
IT1264965B1 (it) | 1993-11-12 | 1996-10-17 | Giorgio Cavallini | Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce |
EP0758895B1 (en) | 1994-04-22 | 2000-01-26 | Pentech Pharmaceuticals, Inc. | Sublingual dosage forms containing apomorphine for use in the treatment of erectile dysfunction |
CA2134038C (en) | 1994-06-16 | 1997-06-03 | David Taiwai Wong | Potentiation of drug response |
IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
US5457121A (en) | 1994-09-02 | 1995-10-10 | Eli Lilly And Company | Cis-hexahydro-5-(1,2,3,4-tetrahydro-2-naphthalenyl)pyrrolo<3,4-c>pyrroles as inhibitors of serotonin reuptake |
US5597826A (en) | 1994-09-14 | 1997-01-28 | Pfizer Inc. | Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist |
ZA958725B (en) | 1994-10-20 | 1997-04-16 | Lilly Co Eli | Treatment of disorders with duloxetine |
EP0714663A3 (en) | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potentiation of drug responses by serotonin 1A receptor antagonists |
US5614523A (en) | 1995-01-17 | 1997-03-25 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
US5576321A (en) | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
US5627196A (en) | 1995-01-17 | 1997-05-06 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
US5789402A (en) | 1995-01-17 | 1998-08-04 | Eli Lilly Company | Compounds having effects on serotonin-related systems |
WO1996024353A1 (en) | 1995-02-10 | 1996-08-15 | Eli Lilly And Company | Methods of treating or preventing psychiatric disorders |
US5624677A (en) | 1995-06-13 | 1997-04-29 | Pentech Pharmaceuticals, Inc. | Controlled release of drugs delivered by sublingual or buccal administration |
BR9610960A (pt) | 1995-10-13 | 1999-03-02 | Neurosearch As | Derivados de 8-azabiciclo [3.2.1] oct -2- eno sua preparação e uso |
US5758911A (en) * | 1996-02-07 | 1998-06-02 | Northrop Grumman Corporation | Linear motion wind driven power plant |
US5897864A (en) | 1996-05-23 | 1999-04-27 | Cohen; Alan J. | Method for treating sexual dysfunction disorders with compositions containing ginkgo biloba |
US5846982A (en) | 1996-06-14 | 1998-12-08 | Eli Lilly And Company | Inhibition of serotonin reuptake |
US5912256A (en) | 1996-06-20 | 1999-06-15 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
US5830500A (en) * | 1996-07-22 | 1998-11-03 | Pentech Pharmaceuticals, Inc. | Low dose fluoxetine tablet |
US6638948B1 (en) | 1996-09-09 | 2003-10-28 | Pentech Pharmaceuticals, Inc. | Amorphous paroxetine composition |
US5672612A (en) | 1996-09-09 | 1997-09-30 | Pentech Pharmaceuticals, Inc. | Amorphous paroxetine composition |
US5910319A (en) | 1997-05-29 | 1999-06-08 | Eli Lilly And Company | Fluoxetine enteric pellets and methods for their preparation and use |
CN1475208A (zh) | 1997-07-01 | 2004-02-18 | �Ʒ� | 舍曲林的缓释剂型 |
KR100446366B1 (ko) | 1997-07-01 | 2004-09-01 | 화이자 인코포레이티드 | 서트랄린 염 및 서트랄린의 서방성 투여형 |
UA68350C2 (en) | 1997-07-01 | 2004-08-16 | Pfizer Prod Inc | Dosage forms of encapsulated sertraline |
FR2765483B1 (fr) | 1997-07-04 | 2000-02-04 | Philippe Gorny | Medicament destine a traiter les dysfonctions erectiles |
US6037360A (en) | 1997-10-28 | 2000-03-14 | Vivus, Incorporated | Administration of 5-HT3 receptor antagonists to treat premature ejaculation |
US6228864B1 (en) | 1997-10-28 | 2001-05-08 | Vivus, Inc. | Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation |
US5922341A (en) | 1997-10-28 | 1999-07-13 | Vivus, Incorporated | Local administration of pharmacologically active agents to treat premature ejaculation |
UA66370C2 (en) | 1997-12-16 | 2004-05-17 | Lilly Co Eli | Arylpiperazines having activity to setotonin 1 receptors |
PA8469101A1 (es) | 1998-04-09 | 2000-09-29 | Pfizer Prod Inc | Ligandos azabiciclicos de receptores 5ht1 |
JP2002518331A (ja) | 1998-06-19 | 2002-06-25 | イーライ・リリー・アンド・カンパニー | セロトニン再取り込みの阻害 |
US6303627B1 (en) | 1998-06-19 | 2001-10-16 | Eli Lilly And Company | Inhibitors of serotonin reuptake |
FR2781671A1 (fr) | 1998-07-28 | 2000-02-04 | Synthelabo | Compositions pharmaceutiques contenant un inhibiteur de la recapture de la serotonine et leur application en therapeutique |
US6150376A (en) | 1998-08-05 | 2000-11-21 | Georgetown University | Bi- and tri-cyclic aza compounds and their uses |
AU766202B2 (en) | 1998-10-13 | 2003-10-09 | Pfizer Products Inc. | Sertraline oral concentrate |
WO2000067729A1 (en) | 1999-05-06 | 2000-11-16 | Pentech Pharmaceuticals, Inc. | Regimen and kit for amelioration of premature ejaculation |
US20010003120A1 (en) * | 1999-05-14 | 2001-06-07 | M. D. Robert Hines | Method for treating erectile dysfunction |
WO2001017521A1 (en) * | 1999-09-03 | 2001-03-15 | Eli Lilly And Company | Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction |
-
2000
- 2000-08-22 WO PCT/US2000/020788 patent/WO2001017521A1/en active IP Right Grant
- 2000-08-22 ES ES00957264T patent/ES2256032T3/es not_active Expired - Lifetime
- 2000-08-22 US US10/049,427 patent/US7718705B1/en not_active Expired - Lifetime
- 2000-08-22 DK DK00957264T patent/DK1225881T3/da active
- 2000-08-22 AU AU68911/00A patent/AU762934B2/en not_active Expired
- 2000-08-22 MX MXPA02001811A patent/MXPA02001811A/es active IP Right Grant
- 2000-08-22 HU HU0202687A patent/HU229150B1/hu active Protection Beyond IP Right Term
- 2000-08-22 AT AT00957264T patent/ATE318135T1/de active
- 2000-08-22 PL PL364924A patent/PL211402B1/pl unknown
- 2000-08-22 CA CA002383785A patent/CA2383785C/en not_active Expired - Lifetime
- 2000-08-22 EP EP07023209A patent/EP1889614A3/en not_active Withdrawn
- 2000-08-22 UA UA2002031755A patent/UA75580C2/uk unknown
- 2000-08-22 DE DE122009000036C patent/DE122009000036I2/de active Active
- 2000-08-22 EP EP00957264A patent/EP1225881B1/en not_active Expired - Lifetime
- 2000-08-22 CZ CZ20020784A patent/CZ299712B6/cs not_active IP Right Cessation
- 2000-08-22 CN CNB008153132A patent/CN1222283C/zh not_active Ceased
- 2000-08-22 BG BG106461A patent/BG65677B1/bg unknown
- 2000-08-22 KR KR1020027002870A patent/KR100719977B1/ko active IP Right Review Request
- 2000-08-22 ES ES06002333T patent/ES2393582T3/es not_active Expired - Lifetime
- 2000-08-22 EP EP06002333A patent/EP1671628B1/en not_active Expired - Lifetime
- 2000-08-22 EA EA200200324A patent/EA004101B1/ru not_active IP Right Cessation
- 2000-08-22 EE EEP200200107A patent/EE05315B1/xx active Protection Beyond IP Right Term
- 2000-08-22 NZ NZ517038A patent/NZ517038A/xx not_active IP Right Cessation
- 2000-08-22 BR BR0014166-6A patent/BR0014166A/pt not_active Application Discontinuation
- 2000-08-22 IL IL14815900A patent/IL148159A0/xx unknown
- 2000-08-22 DE DE60026146T patent/DE60026146T2/de not_active Expired - Lifetime
- 2000-08-22 SI SI200030828T patent/SI1225881T1/sl unknown
- 2000-08-25 TW TW089117155A patent/TWI312678B/zh not_active IP Right Cessation
- 2000-08-25 TW TW094107594A patent/TW200524582A/zh unknown
- 2000-08-25 TW TW098145182A patent/TWI367751B/zh not_active IP Right Cessation
- 2000-08-29 MY MYPI20003983A patent/MY125490A/en unknown
- 2000-08-29 JP JP2000259000A patent/JP3194734B2/ja not_active Expired - Lifetime
-
2002
- 2002-02-14 IL IL148159A patent/IL148159A/en active IP Right Grant
- 2002-02-19 ZA ZA200201407A patent/ZA200201407B/en unknown
- 2002-02-28 HR HR20020189A patent/HRP20020189A2/hr not_active Application Discontinuation
- 2002-03-01 NO NO20021035A patent/NO330562B1/no not_active IP Right Cessation
- 2002-12-16 HK HK02109124.8A patent/HK1047545B/zh unknown
-
2004
- 2004-11-24 US US10/996,587 patent/US20050261377A1/en not_active Abandoned
- 2004-11-24 US US10/996,757 patent/US20050215617A1/en not_active Abandoned
-
2006
- 2006-11-30 HK HK06113173.6A patent/HK1091418A1/xx unknown
-
2012
- 2012-08-29 FR FR12C0052C patent/FR12C0052I2/fr active Active
- 2012-09-11 NO NO2012015C patent/NO2012015I2/no unknown
- 2012-10-11 BE BE2012C040C patent/BE2012C040I2/fr unknown
- 2012-10-23 CY CY2012028C patent/CY2012028I2/el unknown
-
2013
- 2013-05-23 LU LU92204C patent/LU92204I2/fr unknown
-
2014
- 2014-04-10 US US14/250,198 patent/US20140221497A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1091418A1 (en) | Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction | |
ES2165990T3 (es) | Thip para el tratamiento de trastornos del sueño. | |
TR200000755T2 (tr) | Karşıt olma-karşı gelme bozukluğunun tedavisi. | |
CY1109191T1 (el) | Μια νεα χρηση της δεφεριπρονης | |
BR0308813A (pt) | Tratamento de tuberculose usando derivados de pleuromutilina | |
WO2004110380A3 (en) | Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents | |
HUP0302436A2 (hu) | Antidepresszáns gyógyszerek által kiváltott szexuális rendellenességek kezelése apomorfinnal | |
EA199800864A1 (ru) | Способ лечения при боли, вызванной мигренью | |
AU2002347984A1 (en) | Use of norepinephrine reuptake inhibitors for the treatment of tic disorders | |
PT1183046E (pt) | Derivado de aminotetralina para a terapia de doencas cardiovasculares | |
HK1080768A1 (en) | Use of epothilone derivatives for the treatment ofhyperparathyroidism | |
CY1118068T1 (el) | Η χρηση δαποξετινης, ενος ταχειας-εναρξης επιλεκτικου αναστολεα εκ νεου αναληψης σepοτονινης για την θepαπευτικη αντιμετωπιση σεξουαλικης δυσλειτουργιας | |
PA8505301A1 (es) | Metodo para tratar el mal de parkinson a traves de la administracion de ( - ) - 5 ceto-2-n- propilamino - tetrahidrotetralina | |
CR6602A (es) | Metodos de uso de inhbidores selectivos de reasorcion de serotonina de rapido inicio, para tratar la disfuncion sexual | |
ECSP993026A (es) | Combinacion de fentolamina y apomorfina para el tratamiento de la funcion y disfuncion sexual humana | |
ECSP003771A (es) | Metodo para prevenir la diarrea | |
EA200000514A1 (ru) | Способ лечения эректильной дисфункции |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SPCF | Filing of supplementary protection certificate |
Free format text: PRODUCT NAME: PRILIGY; NAT. REG. NO/DATE: MTNR 10-7834/35 20120514; FIRST REG. NO/DATE: FI , 24353/4 20090205 Spc suppl protection certif: 2012015 Filing date: 20120911 |
|
SPCG | Granted supplementary protection certificate |
Free format text: PRODUCT NAME: PRILIGY; NAT. REG. NO/DATE: MTNR 10-7834/35 20120514; FIRST REG. NO/DATE: FI , 24353/4 20090205 Spc suppl protection certif: 2012015 Filing date: 20120911 Extension date: 20240205 |
|
CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: ALLERGAN SALES, US |
|
SPCS | Change of name or address of the owner of a supplementary protection certificate |
Owner name: ALLERGAN SALES, US Spc suppl protection certif: 2012015 |
|
MK1K | Patent expired |